You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

~ Buy the VANFLYTA (quizartinib dihydrochloride) Drug Profile, 2024 PDF Report in the Report Store ~

Bulk Pharmaceutical API Sources for VANFLYTA


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for VANFLYTA

Vendor Vendor Homepage Vendor Sku API Url
ISpharm ⤷  Sign Up I14-17017 ⤷  Sign Up
Adooq BioScience ⤷  Sign Up AC220 - Quizartinib ⤷  Sign Up
Inhibitor 2 ⤷  Sign Up AC-220 ⤷  Sign Up
BioChemPartner ⤷  Sign Up BCPP000443 ⤷  Sign Up
AbMole Bioscience ⤷  Sign Up 1641 ⤷  Sign Up
BioChemPartner ⤷  Sign Up BCP9000223 ⤷  Sign Up
AKos Consulting & Solutions ⤷  Sign Up AKOS015891557 ⤷  Sign Up
>Vendor >Vendor Homepage >Vendor Sku >API Url

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.